KLOR-CON M
NDC 0245-5319, potassium chloride, tablet, extended release, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 0245-5319
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074726
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0245-5319 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CHLORIDE1500 mg/1
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0245-5319-01 | 00245531901 | 100 BLISTER PACK in 1 CARTON (0245-5319-01) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0245-5319-89) |
| 0245-5319-10 | 00245531910 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-10) |
| 0245-5319-11 | 00245531911 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-11) |
| 0245-5319-15 | 00245531915 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-15) |
| 0245-5319-90 | 00245531990 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0245-5319-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b89910f6-4ff5-4a62-8269-696f7c10e4f6NADAC price for package 00245531901
GET /v1/drugs/nadac/00245531901NADAC price for package 00245531910
GET /v1/drugs/nadac/00245531910NADAC price for package 00245531911
GET /v1/drugs/nadac/00245531911NADAC price for package 00245531915
GET /v1/drugs/nadac/00245531915NADAC price for package 00245531990
GET /v1/drugs/nadac/00245531990
Use it
Look up 0245-5319 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0245-5319 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0245-5319. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.